Quality Assurance
Navigating Regulatory CMC Success: Expert Services for Drug Development and Commercialization
Additionally, Enkrisi provides data audit services to ensure data integrity and validation. Clients can receive recommendations for improvement and support for regulatory inspections.
Learn more about Quality Assurance
How we can help
How we can help
What makes Enkrisi your ideal choice?
In addition to these audits, we also offer gap assessments and PAI readiness assessments to help clients identify areas where they may be falling short of regulatory requirements and ensure they are prepared for any regulatory inspections. We also provide guidance and support for clients seeking commercial readiness for their products.
Our data audit services cover data integrity and validation to ensure that clients’ data is accurate, complete, and reliable. We help clients assess the integrity of their data, identify potential areas of concern, and develop strategies to address any issues.
Your success,
stories
Enkrisi’s Regulatory Strategy Team: Highly Skilled and Effective in the Pharmaceutical Industry
As someone who has worked in the pharmaceutical industry for several years, I can say without hesitation that Enkrisi’s Regulatory strategy team is top-notch. Their team of experts is highly skilled at navigating the complex regulatory landscape, and they are always on top of the latest developments in the industry. I highly recommend their services to anyone looking to bring a new drug to market. Enkrisi’s Regulatory Consultants have a strong history of effective communication. They can author critical messages supported by scientifically-cohesive narratives, reports, and data summaries for your investigational and marketing submission documents.
Lisa D
VP, Regulatory Affairs and Quality Assurance
Enkrisi’s Quality and Expertise Critical to Drug Sponsor Success
Since transitioning to a drug sponsor role, I have continued to rely on Enkrisi for their guidance and assistance in ensuring our drug product meets regulatory standards and is ready for commercial distribution. Your team’s attention to detail and commitment to quality have been crucial to our success. Enkrisi’s experienced contract regulatory writers can provide Common Technical Document (CTD) content, FDA Briefing Books, meeting minutes, slides, and more to help you meet or beat every deadline, challenge and improve document quality, and become someone you can unquestionably rely on.
Lynn G
SVP Regulatory Affairs
Enkrisi: Top-Tier Drug Development Support for Due Diligence and Licensing Deals
Enkrisi’s drug development support services are among the best I have ever encountered for due diligence and licensing deals. Their team of experts is highly knowledgeable about all aspects of CMC operations management, and they are always willing to provide guidance and support to help their clients succeed. They are genuinely passionate about what they do and are committed to helping their clients bring new, innovative drugs to market.
Brian S
Operating Partner - Life Sciences
Enkrisi: Exceptional Drug Development Support from Research to Commercial Distribution
Enkrisi’s drug development support is truly exceptional. From the earliest stages of research to the final phases of clinical trials, their team is there every step of the way, providing guidance and support to help ensure success. Their expertise in CMC operations management is particularly impressive, and they are always willing to go above and beyond to help their clients achieve their goals. If you are developing a pharmaceutical drug product for commercial distribution, seeking expert assistance with CMC regulatory work from Enkrisi can help you manage and lower regulatory risk and avoid regulatory delay.
Jamie D
Director of CMC
Discover Our Full Expertise in:
Discover Our Full Expertise in:
Latests insights about EnkrisiGPT
The latest in biotech for your ears
The VirtualPharm Podcast is an audio series that covers topics related to compliance and regulatory affairs in the Lifesciences industry. Each episode, hosted by an expert in the topic with decades of experience, offers listeners detailed insight into the changing regulatory environment.
